Published in Cell Mol Neurobiol on December 01, 2002
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol (2005) 1.32
Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. Biophys J (2007) 1.27
Cellular FLICE-inhibitory protein: an attractive therapeutic target? Expert Opin Ther Targets (2003) 1.21
An antibody to the beta-secretase cleavage site on amyloid-beta-protein precursor inhibits amyloid-beta production. J Alzheimers Dis (2006) 0.90
Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline. J Clin Invest (2014) 0.89
Development and validation of a yeast high-throughput screen for inhibitors of Aβ₄₂ oligomerization. Dis Model Mech (2011) 0.88
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics. Alzheimers Res Ther (2014) 0.86
Mass spectrometry-based screening for inhibitors of beta-amyloid protein aggregation. Anal Chem (2005) 0.80
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature (1987) 17.08
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A (1985) 16.10
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans. Biochem J (1999) 8.68
The molecular pathology of Alzheimer's disease. Neuron (1991) 8.21
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol (2000) 8.07
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature (2001) 7.35
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (2001) 6.78
Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron (1994) 6.41
Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature (1999) 5.77
Statins and the risk of dementia. Lancet (2000) 5.65
Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature (1999) 5.48
Translating cell biology into therapeutic advances in Alzheimer's disease. Nature (1999) 5.42
Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med (2000) 4.99
Natural products in drug discovery and development. J Nat Prod (1997) 4.94
Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature (2000) 4.68
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci (1993) 4.60
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem (2001) 4.45
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A (1994) 4.33
Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron (2000) 4.29
Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med (1998) 4.17
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci (1992) 4.10
Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci (2001) 3.85
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 3.50
Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A (1993) 3.16
Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron (1996) 3.14
Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci U S A (2000) 2.96
Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med (2001) 2.75
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature (2002) 2.71
Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem (1996) 2.68
A portrait of Alzheimer secretases--new features and familiar faces. Science (2001) 2.42
Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc Natl Acad Sci U S A (1993) 2.41
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J Biol Chem (2000) 2.33
Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med (1998) 2.32
Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci (2000) 2.22
Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science (2000) 2.01
Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci (2001) 1.98
Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci (2001) 1.95
Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem (2001) 1.86
Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem (2001) 1.82
Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem (1996) 1.79
The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol (1998) 1.77
Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun (1996) 1.73
Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol (2000) 1.69
Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett (2000) 1.65
The C-terminus of the beta protein is critical in amyloidogenesis. Ann N Y Acad Sci (1993) 1.61
Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry (2000) 1.54
Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet (2000) 1.54
The Alzheimer family of diseases: many etiologies, one pathogenesis? Proc Natl Acad Sci U S A (1997) 1.53
Selective inhibition of Abeta fibril formation. J Biol Chem (1996) 1.53
Zn2+ interaction with Alzheimer amyloid beta protein calcium channels. Proc Natl Acad Sci U S A (1996) 1.49
Recognition sequence design for peptidyl modulators of beta-amyloid aggregation and toxicity. Biochemistry (1999) 1.45
Alzheimer's disease. Antibody clears senile plaques. Nature (1999) 1.45
Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation. J Biol Chem (2000) 1.44
Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc Natl Acad Sci U S A (2002) 1.44
Set back to Alzheimer vaccine studies. Nat Med (2002) 1.43
Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J Biol Chem (1996) 1.42
Cell-type and amyloid precursor protein-type specific inhibition of A beta release by bafilomycin A1, a selective inhibitor of vacuolar ATPases. J Biol Chem (1995) 1.40
Inhibition of beta-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron (1995) 1.35
Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J (2000) 1.32
A strategy for designing inhibitors of beta-amyloid toxicity. J Biol Chem (1996) 1.28
Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J Neurosci (2000) 1.27
Biodiversity and drug discovery--a symbiotic relationship. Phytochemistry (2000) 1.27
Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF. Biochemistry (2001) 1.26
Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons. J Neurochem (1999) 1.23
A fluid connection: cholesterol and Abeta. Proc Natl Acad Sci U S A (2001) 1.22
Long amyloid beta-protein secreted from wild-type human neuroblastoma IMR-32 cells. Biochemistry (1995) 1.21
beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem Res Toxicol (1997) 1.16
Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J Biol Chem (1998) 1.12
beta-Cyclodextrin interacts with the Alzheimer amyloid beta-A4 peptide. FEBS Lett (1994) 1.11
Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci (1994) 1.11
Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci (1997) 1.10
Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry (1996) 1.08
Calcium as sculptor and destroyer of neural circuitry. Exp Gerontol (1992) 1.06
Chrysamine-G, a lipophilic analogue of Congo red, inhibits A beta-induced toxicity in PC12 cells. Life Sci (1998) 1.06
Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol Aging (1996) 1.06
Complex N-linked glycosylated nicastrin associates with active gamma-secretase and undergoes tight cellular regulation. J Biol Chem (2002) 1.06
Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma. J Neurobiol (1999) 1.05
The protease inhibitor, MG132, blocks maturation of the amyloid precursor protein Swedish mutant preventing cleavage by beta-Secretase. J Biol Chem (2000) 0.99
Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol (1994) 0.98
Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci Lett (1995) 0.98
Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease. Curr Med Chem (2000) 0.98
Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Prog Neurobiol (2000) 0.97
Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol (2000) 0.97
Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation. Biochem J (1999) 0.97
Transthyretin binds amyloid beta peptides, Abeta1-42 and Abeta1-40 to form complex in the autopsied human kidney - possible role of transthyretin for abeta sequestration. Neurosci Lett (2000) 0.96
Processing of Alzheimer A beta-amyloid precursor protein: cell biology, regulation, and role in Alzheimer disease. Int Rev Neurobiol (1994) 0.95
High throughput screens for the identification of compounds that alter the accumulation of the Alzheimer's amyloid beta peptide (Abeta). J Neurosci Methods (2001) 0.93
Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF. Neuron (1996) 0.93
Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization. Biochem J (2000) 0.93
Alzheimer's disease and the amyloid beta protein: What is the role of amyloid? J Neurochem (1999) 0.93
Nicotine enhances the biosynthesis and secretion of transthyretin from the choroid plexus in rats: implications for beta-amyloid formation. J Neurosci (2000) 0.92
A perspective on inflammation in Alzheimer's disease. Ann N Y Acad Sci (2000) 0.91
Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease. Drug Discov Today (2001) 0.90
Proteomics in neuroscience: from protein to network. J Neurosci (2001) 0.89
Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol (2007) 1.37
Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. FASEB J (2004) 1.35
Structural and morphological characterization of hemozoin produced by Schistosoma mansoni and Rhodnius prolixus. FEBS Lett (2005) 1.27
Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. J Biol Chem (2008) 1.20
Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor protein. J Mol Biol (2006) 1.07
Human apolipoprotein A-I binds amyloid-beta and prevents Abeta-induced neurotoxicity. Int J Biochem Cell Biol (2008) 1.07
Closed conformation of the active site loop of rabbit muscle triosephosphate isomerase in the absence of substrate: evidence of conformational heterogeneity. J Mol Biol (2003) 1.02
Amyloid-β triggers the release of neuronal hexokinase 1 from mitochondria. PLoS One (2010) 0.98
Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure. FASEB J (2004) 0.97
Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration. J Neurochem (2007) 0.97
Inhibition of choline acetyltransferase as a mechanism for cholinergic dysfunction induced by amyloid-β peptide oligomers. J Biol Chem (2012) 0.96
Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature. J Biol Chem (2003) 0.88
Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology (2005) 0.88
Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP). J Biol Chem (2004) 0.87
Solution studies and structural model of the extracellular domain of the human amyloid precursor protein. Biophys J (2002) 0.86
Small molecule inhibitors of lysozyme amyloid aggregation. Cell Biochem Biophys (2006) 0.86
Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231). J Biol Chem (2006) 0.85
Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta. J Biol Chem (2005) 0.85
Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound. FASEB J (2005) 0.84
Folding of a de novo designed native-like four-helix bundle protein. J Biol Chem (2002) 0.82
Heparin-binding sites in granulocyte-macrophage colony-stimulating factor. Localization and regulation by histidine ionization. J Biol Chem (2005) 0.82
Protein folding, misfolding and aggregation: evolving concepts and conformational diseases. Protein Pept Lett (2005) 0.82
Expression profile of rat hippocampal neurons treated with the neuroprotective compound 2,4-dinitrophenol: up-regulation of cAMP signaling genes. Neurotox Res (2009) 0.82
Functional properties of purified vicilins from cowpea (Vigna unguiculata) and pea (Pisum sativum) and cowpea protein isolate. J Agric Food Chem (2003) 0.81
Predissociated dimers and molten globule monomers in the equilibrium unfolding of yeast glutathione reductase. Biophys J (2003) 0.81
Cyclic AMP enhancers and Abeta oligomerization blockers as potential therapeutic agents in Alzheimer's disease. Curr Alzheimer Res (2007) 0.81
Inhibition of yeast glutathione reductase by trehalose: possible implications in yeast survival and recovery from stress. Int J Biochem Cell Biol (2004) 0.81
Folding and stability of the extracellular domain of the human amyloid precursor protein. J Biol Chem (2003) 0.80
Novel neuroprotective, neuritogenic and anti-amyloidogenic properties of 2,4-dinitrophenol: the gentle face of Janus. IUBMB Life (2006) 0.80
Acid- and pressure-induced (un)folding of yeast glutathione reductase: competition between protein oligomerization and aggregation. Int J Biochem Cell Biol (2005) 0.78
Equilibrium unfolding and conformational plasticity of troponin I and T. Eur J Biochem (2002) 0.77
Folding and stability of a coiled-coil investigated using chemical and physical denaturing agents: comparative analysis of polymerized and non-polymerized forms of alpha-tropomyosin. Int J Biochem Cell Biol (2005) 0.77
Secreted human amyloid precursor protein binds semaphorin 3a and prevents semaphorin-induced growth cone collapse. PLoS One (2011) 0.77
Neuroprotection against Abeta and glutamate toxicity by melatonin: are GABA receptors involved? Neurotox Res (2003) 0.77
Amyloid-β decreases nitric oxide production in cultured retinal neurons: a possible mechanism for synaptic dysfunction in Alzheimer's disease? Neurochem Res (2010) 0.76
Long-lived conformational isomerism of protein dimers: the role of the free energy of subunit association. Biophys J (2006) 0.75
Redesigning the folding energetics of a model three-helix bundle protein by site-directed mutagenesis. J Biol Chem (2003) 0.75
Conformational plasticity of DM43, a metalloproteinase inhibitor from Didelphis marsupialis: chemical and pressure-induced equilibrium (un)folding studies. Biochim Biophys Acta (2009) 0.75
Reductive inactivation of yeast glutathione reductase by Fe(II) and NADPH. Comp Biochem Physiol A Mol Integr Physiol (2007) 0.75
Interrogating global gene expression in rat neuronal cultures using SAGE. Neurotox Res (2007) 0.75